An Anti-Inflammatory Drug (Mefenamic Acid) Incorporated in Biodegradable Alginate Beads: Development and Optimization of the Process Using Factorial Design

REFERENCES

• Bodmeier R, Wang J. Microencapsulation of drugs with aqueous colloidal polymer dispersions. J. Pharm. Sci. 1993; 82: 1–1194
   PubMed Web of Science ®Google Scholar
• Kim CK, Lee EJ. The controlled release of blue dextran from alginate beads. Int. J. Pharm. 1992; 79: 11–19
   Web of Science ®Google Scholar
• Çalış S, Arıca B, Atilla P, Durku T, Çakar N, Hıncal A. Effect of ibuprofen and ibuprofen incorporated biodegradable alginate beads on gastric and duodenal mucosa (a comparative histological study). Controlled Release Society 30th Annual Meeting Proceedings. July, 19–23, 2003; 495
   Google Scholar
• Tonnesen HH, Karlsen J. Alginate in drug delivery systems. Drug Dev. Ind. Pharm. 2002; 28: 621–630
   PubMed Web of Science ®Google Scholar
• Badwan AA, Abumaloohs A, Salam E, Abukalaf A, Jawan O. A sustained release drug delivery system using alginate beads. Drug Dev. Ind. Pharm. 1985; 11: 239–256
   Web of Science ®Google Scholar
• Shu XZ, Zhu KJ. The release behavior of brilliant blue from calcium-alginate gel beads coated by chitosan: the preparation method effect. Eur. J. Pharm. Biopharm. 2002; 53: 93–201
   Web of Science ®Google Scholar
• Gaudio PD, Colombo P, Colombo G, Russo P, Sonvico F. Mechanisms of formation and disintegration of alginate beads obtained by prilling. Int. J. Pharm. 2005; 302: 1–9
   PubMed Web of Science ®Google Scholar
• Türkoğlu M, Gürsoy A, Eroğlu L, Okar I. Effect of aqueous polymer dispersions on properties of diclofenac/alginate beads and in vivo evaluations in rats. STP Pharma Sci. 1997; 7: 135–140
   Google Scholar
• Sugawara S, Imai T, Otagiri M. The controlled release of prednisolone uing alginate gel. Pharm. Res. 1994; 11: 272–277
   PubMed Web of Science ®Google Scholar
• Pillay V, Dango CM, Govender T, Moopanar KR, Hurban SN. Ionotropic gelation:encapsulaton of indomethacin in calcium alginate gel discs. J. Microen. 1998; 15: 215–226
   PubMed Web of Science ®Google Scholar
• Halder A, Maiti S, Sa B. Entrapment efficiency and release characteristics of polyethyleneimine-treated or -untreated calcium alginate beads loaded with propranolol-resin complex. Int. J. Pharm. 2005; 302: 84–94
   PubMed Web of Science ®Google Scholar
• Martindale. The Extra Pharmacopoeia31st. The Pharmaceutical Press, London 1998; 58–59
   Google Scholar
• European Pharmacopoeia4th. Council of Europea, Strasbourg 2002
   Google Scholar
• Yurdasiper A, Kaynarsoy B, Sevgi F, Turunç E, Yalçın A. Effect of mefenamic acid and its microsponge formulations on the rat brain cortex DNA. Proceed. 13th Inter. Pharm. Technol. Symp, AntalyaTurkey, Sept, 10–13, 2006; 75–76
   Google Scholar
• Joo Y, Kim H, Woo R, Park C. Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models. Mol. Pharm. 2006; 69: 76–84
   PubMed Web of Science ®Google Scholar
• Ozsoy Y, Berşigadi N. Preparation of mefenamic acid sustained release beads based on κ-carregeenana. Boll. Chim. Farmac. 2000; 139: 89–92
   PubMedGoogle Scholar
• Betageri GV, Kurumaddali KR, Ravis WR. Preparation and in vitro evaluation of mefenamic acid sustained release beads. Drug Dev. Ind. Pharm. 1995; 21: 265–275
   Web of Science ®Google Scholar
• Ramadan EM, El-Helw A, El-Said Y. Effect of encapsulation of mefenamic acid with cationic Eudragit E on its bioavailability and gastric ulcerogenic activity in rabbits. J. Microen. 1987; 4: 125–132
   PubMedGoogle Scholar
• Lalla JK, Ahuja PL. Drug targeting using non-magnetic and magnetic albumin-globulin mix microspheres of mefenamic acid. J. Microen. 1991; 8: 37–52
   PubMed Web of Science ®Google Scholar
• Sevgi F, Ozyazıcı M, Kaynarsoy B, Ozyurt D, Pekçetin C. Histological evaluation of drug-loaded alginate beads and Eudragit microspheres. Proceed. 13th Inter. Pharm. Technol. Symp, AntalyaTurkey, Sept, 10–13, 2006
   Google Scholar
• Sevgi F, Sarpaş B, Yurdasiper A. The effect of tabletting on the release characteristics of mefenamic acid microspheres. European Conference on Drug Delivery and Pharmaceutical Technology, Sevilla-Spain, May, 10–12, 2004; 326
   Google Scholar
• Gungor S, Yildiz A, Ozsoy Y, Cevher E, Araman A. Investigations on mefenamic acid sustained release tablets with water-insoluble gel. Il. Farmaco 2003; 58: 397–401
   PubMedGoogle Scholar
• Ozyazici M, Sevgi F, Ertan G. Sustained-release dosage form of nicardipine hydrochloride: Application of factorial design and effect of surfactant on release kinetics. Drug Dev. Ind. Pharm. 1997; 23: 761–770
   Web of Science ®Google Scholar
• Gohel MC, Amin AF. Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. J. Control. Release. 1998; 51: 115–122
   PubMed Web of Science ®Google Scholar
• Sevgi F, Ozyazici M, Güneri T. Sustained-release dosage form of phenylpropanolamine hydrochloride (3). Application of factorial design. J. Microen. 1994; 11: 439–444
   PubMed Web of Science ®Google Scholar
• Kulkarni AR, Soppimath KS, Aminabhavi M. Controlled release of diclofenac sodium from sodium alginate beads crosslinked with glutaraldehyde. Pharm. Acta Helv. 1999; 74: 29–36
   Google Scholar
• 27. The United States Pharmacopeia 24, United States Pharmacopeial Convention, Inc., Rockville, MD; 2000.
   Google Scholar
• Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 1985; 60: 110–111
   PubMedGoogle Scholar
• Ritger PL, Peppas N. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Control. Release 1987; 5: 37–42
   Google Scholar
• Ege MA, Karasulu HY, Karasulu E, Ertan G. A computer program designed for in vitro dissolution kinetics, in vitro-in vivo kinetic correlations and routine applications, in: 4th Central European Symposium on Pharmaceutical Technology. Scientia Pharmaceutical September 23–25, 2001, Suppl. 1 Band 69: S127–S128, http://pharm.ege.edu.tr/applications/
   Google Scholar
• Østberg T, Graffner C. Calcium alginate matrices for oral multiple unit administration: III. Influence of calcium concentration, amount of drug added and alginate characteristics on drug release. Int. J. Pharm. 1994; 111: 271–282
   Web of Science ®Google Scholar
• Bodmeier R, Oh-K H, Pramar Y. Preparation and evaluation of drug-containing chitosan beads. Drug Dev. Ind. Pharm. 1989; 15: 1475–1494
   Web of Science ®Google Scholar
• Segi N, Yotsuyanagi T, Ikeda K. Interaction of calcium-induced alginate gel beads with propranolol. Chem. Pharm. Bull. 1989; 37: 3092–3095
   Web of Science ®Google Scholar
• Haug A, Smidsrod O. The effect of divalent metals on the properties of alginate solutions. Acta Chem. Scand. 1965; 17: 341–351
   Google Scholar
• Takka S, Ocak OH, Acarturk F. Formulation and investigation of nicardipine HCl–alginate gel beads with factorial design-based studies. Europ. J. Pharm. Sci. 1998; 6: 241–246
   PubMed Web of Science ®Google Scholar
• Su XY, Al-Kansas R, Po ALW. Statistical modelling of ibuprofen release from spherical lipophilic matrices. Eur. J. Pharm. Biopharm. 1994; 40: 73–76
   Web of Science ®Google Scholar
• Karasulu E, Karasulu HY, Ertan G, Kirilmaz L, Güneri T. Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates. Eur. J. Pharm. Sci. 2003; 19: 99–104
   PubMed Web of Science ®Google Scholar